Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05309655 · ClinicalTrials.gov registry record · NA
Cardiac Outcomes With Near-Complete Estrogen Deprivation
A NA study of Breast Cancer and Triple Negative Breast Cancer, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 3
- Study locations
NCT05309655 is a NA study of Breast Cancer and Triple Negative Breast Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 90 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05309655, a NA study of Breast Cancer and Triple Negative Breast Cancer, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to understand what effect near complete estrogen deprivation (NCED) therapy has on the heart in breast cancer patients. Investigators want to understand if NCED changes how the heart works.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Electrocardiogram
- DRUG Adenosine Stress Cardiac Magnetic Resonance Imaging
- DIAGNOSTIC_TEST Computed Tomography Angiogram
- OTHER Laboratory Testing
- BEHAVIORAL Quality of Life Survey
Study Locations (3)
North Carolina
- Duke Cancer Center - Durham
- Wake Forest Baptist Comprehensive Cancer Center - Winston-Salem
Virginia
- Virginia Commonwealth University Massey Cancer Center - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-09-02 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05309655
The ClinicalTrials.gov registry entry for NCT05309655 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Electrocardiogram is the first listed.
NCT05309655 reports 3 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT05309655 about?
NCT05309655 is a clinical study titled "Cardiac Outcomes With Near-Complete Estrogen Deprivation". The purpose of this research study is to understand what effect near complete estrogen deprivation (NCED) therapy has on the heart in breast cancer patients. Investigators want to understand if NCED changes how the heart works.
What is the current status of trial NCT05309655?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2022-09-02. Estimated completion is 2028-12-01.
What conditions does trial NCT05309655 study?
This clinical trial studies the following conditions: Breast Cancer, Triple Negative Breast Cancer, Cardiovascular Complications.
What interventions are being tested in trial NCT05309655?
The interventions under investigation include: Electrocardiogram (DIAGNOSTIC_TEST), Adenosine Stress Cardiac Magnetic Resonance Imaging (DRUG), Computed Tomography Angiogram (DIAGNOSTIC_TEST), Laboratory Testing (OTHER), Quality of Life Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT05309655?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05309655 being conducted?
This trial has 3 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.